Thermo Fisher Scientific Inc. (TMO) key performance indicators and operating metrics (11 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Operating Margin | 21.80 percent | FY2026-Q1 |
| Free Cash Flow | 825M | FY2026-Q1 |
| Organic Revenue Growth | 1.00 percent | FY2026-Q1 |
| Adjusted Earnings per Share | 5.44 USD_per_share | FY2026-Q1 |
| Adjusted Operating Income | 2.4B | FY2026-Q1 |
| Operating Margin (Generally Accepted Accounting Principles) | 16.90 percent | FY2026-Q1 |
| Life Sciences Segment Revenue | 2.18B | FY2026-Q1 |
| Laboratory Products and Biopharma Services Segment Revenue | 6.04B | FY2026-Q1 |
| Specialty Diagnostics Segment Revenue | 1.14B | FY2026-Q1 |
| Reported Revenue Growth | 7.00 percent | FY2025-Q4 |
| Analytical Instruments Segment Revenue | 1.89B | FY2025-Q3 |
Back to TMO overview · TMO earnings · TMO holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.